1. Home
  2. MYGN vs DNUT Comparison

MYGN vs DNUT Comparison

Compare MYGN & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYGN
  • DNUT
  • Stock Information
  • Founded
  • MYGN 1991
  • DNUT 1937
  • Country
  • MYGN United States
  • DNUT United States
  • Employees
  • MYGN N/A
  • DNUT N/A
  • Industry
  • MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • DNUT Food Chains
  • Sector
  • MYGN Health Care
  • DNUT Consumer Staples
  • Exchange
  • MYGN Nasdaq
  • DNUT Nasdaq
  • Market Cap
  • MYGN 2.0B
  • DNUT 1.9B
  • IPO Year
  • MYGN 1995
  • DNUT 2021
  • Fundamental
  • Price
  • MYGN $17.57
  • DNUT $12.42
  • Analyst Decision
  • MYGN Buy
  • DNUT Buy
  • Analyst Count
  • MYGN 12
  • DNUT 9
  • Target Price
  • MYGN $28.18
  • DNUT $15.56
  • AVG Volume (30 Days)
  • MYGN 783.2K
  • DNUT 1.3M
  • Earning Date
  • MYGN 11-07-2024
  • DNUT 11-07-2024
  • Dividend Yield
  • MYGN N/A
  • DNUT 1.13%
  • EPS Growth
  • MYGN N/A
  • DNUT N/A
  • EPS
  • MYGN N/A
  • DNUT N/A
  • Revenue
  • MYGN $802,200,000.00
  • DNUT $1,739,779,000.00
  • Revenue This Year
  • MYGN $13.95
  • DNUT $1.30
  • Revenue Next Year
  • MYGN $9.71
  • DNUT $6.15
  • P/E Ratio
  • MYGN N/A
  • DNUT N/A
  • Revenue Growth
  • MYGN 14.78
  • DNUT 8.06
  • 52 Week Low
  • MYGN $16.00
  • DNUT $9.18
  • 52 Week High
  • MYGN $29.30
  • DNUT $17.84
  • Technical
  • Relative Strength Index (RSI)
  • MYGN 21.33
  • DNUT 66.97
  • Support Level
  • MYGN $16.86
  • DNUT $11.02
  • Resistance Level
  • MYGN $22.92
  • DNUT $11.82
  • Average True Range (ATR)
  • MYGN 1.00
  • DNUT 0.34
  • MACD
  • MYGN -0.45
  • DNUT 0.09
  • Stochastic Oscillator
  • MYGN 10.32
  • DNUT 84.73

About MYGN Myriad Genetics Inc.

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S., includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line; International includes operations in the U.K., Ireland, Australia, New Zealand, and Mexico; and Market Development includes franchise operations across the globe, as well as operations in Japan. It derives maximum revenue from U.S. Segment.

Share on Social Networks: